AIDS, a life-threatening disease that remained stubbornly immune against any treatment or vaccination – In the last years of the 20th Century, the world was hit by a plague epidemic proportions. In the developed countries of the West, AIDS was slowly brought under control by a combination of education, prevention and modern medicines. But in developing countries, where health issues were often poor AIDS began to riot. By 2000, 25 million people in Africa alone were i … Read more »

AIDS, a life-threatening disease that remained stubbornly immune against any treatment or vaccination – In the last years of the 20th Century, the world was hit by a plague epidemic proportions. In the developed countries of the West, AIDS was slowly brought under control by a combination of education, prevention and modern medicines. But in developing countries, where health issues were often poor AIDS began to riot. By 2000 25 million people were infected in Africa alone with the disease. Millions have died. Almost all drugs that have been developed AIDS treated – with great effort – from the big Western pharmaceutical companies. These drugs were expensive to produce and often difficult to manage. They called income and sales structures, which were often sorely lacking in the Third World. Increasingly, activists are demanding that the pharmaceutical companies, the AIDS epidemic respond with drastic measures, so that their medications free or waiver of patent rights that had long protected their intellectual property. The pharmaceutical company needed to respond to their critics. The question was, how?
«Hide

from
Nicholas Bartlett,
Debora L. Spar
Source: HBS Premier Case Collection
24 pages.
Publication Date: Jun 13, 2002. Prod #: 702049-PDF-ENG
Life, Death, and Property Rights: The Pharmaceutical Industry Faces AIDS in Africa HBR case solution